NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM5551943 Query DataSets for GSM5551943
Status Public on Sep 02, 2021
Title 7 caki cl2a_(miRNA-4_0)
Sample type RNA
 
Source name ccRCC Caki sunitinib resistant cell line
Organism Homo sapiens
Characteristics cell line: Caki-1
cell type: clear cell renal cell carcinoma (ccRCC)
drug resistance: sunitinib resistant
Treatment protocol Sunitinib concentrations were increased incrementally by 0.5uM steps until the IC50 values reached >10uM
Growth protocol cells were grown over several months either with sunitinib (two clones per cell line) or without (parental cell lines).
Extracted molecule total RNA
Extraction protocol RNA was extracted for cells with Trizol using standard protocols
Label biotin
Label protocol standard Affymetrix protocol
 
Hybridization protocol standard Affymetrix protocol
Scan protocol standard Affymetrix protocol
Description miRNA expression data from clone 2 of Caki sunitinib resistant ccRCC cell line
Data processing RMA processed in affymetrix TAC (v.4.0.2)
 
Submission date Aug 31, 2021
Last update date Sep 03, 2021
Contact name charles lawrie
E-mail(s) charles.lawrie@biodonostia.org
Phone 0622080463
Organization name Biodonostia Research Institute
Department Oncology
Street address Paseo Mikeletegi, 83- planta 3
City Donsotia-San Sebastian
ZIP/Postal code 20012
Country Spain
 
Platform ID GPL30571
Series (1)
GSE183140 Integrated miRNA-genomic analysis of sunitinib resistance in clear cell renal cell carcinoma (CCRCC) cell lines

Supplementary file Size Download File type/resource
GSM5551943_7_caki_cl2a_miRNA-4_0.CEL.gz 757.5 Kb (ftp)(http) CEL
GSM5551943_7_caki_cl2a_miRNA-4_0_.rma-dabg.chp.gz 284.7 Kb (ftp)(http) CHP
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap